Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag The FDA now allows most new drugs to be approved based on just one clinical trial to speed up access and lower costs.

flag The FDA has revised its drug approval process, allowing most new drugs to be approved based on a single clinical trial instead of the traditional two, citing advances in science and data analysis. flag The change, effective immediately, aims to speed up access to treatments, reduce development costs, and lower drug prices, particularly for rare and serious conditions. flag While the agency maintains strong safety standards and can still require additional studies post-approval, experts remain divided on whether the shift improves efficiency or risks patient safety.

4 Articles